Browse

While early, the findings suggest the therapy could be superior to Novartis’ Vijoice at treating “vascular anomalies,” a cluster of chronic conditions with few available treatments.

A new set of lists ranks drug company laboratories on two criteria: innovation and invention.

Affordable Care Act changes, drinking while pregnant, and more health news from Morning Rounds